AMGEN LIMITED -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 25.395.897 0 1
2018 0 6.248.931 0 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
BAYER3
SANOFIAVENTIS3
ASTRAZENECA2
ELI LILLY AND COMPANY LIMITED2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
GRUNENTHAL2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
NOVARTIS PHARMA2
PFIZER LIMITED2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TAKEDA PHARMACEUTICALS INTERNATIONAL2
UCB BIOPHARMA2
ACADEMISCH ZIEKENHUIS GRONINGEN1
AGENZIA ITALIANA DEL FARMACO1
ALEXION SERVICES EUROPE SPRL1
ALZHEIMER EUROPE1
ASTELLAS PHARMA EUROPE BV1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
COVANCE LABORATORIES1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ERESEARCH TECHNOLOGY INC1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION1
F HOFFMANNLA ROCHE1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FORUM DES PATIENTS EUROPEENS1
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG1
FUNDACIO SANT JOAN DE DEU1
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA1
H LUNDBECK AS1
HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY1
ICON CLINICAL RESEARCH LIMITED1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD1
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS1
IXSCIENT LIMITED1
JANSSEN PHARMACEUTICA NV1
KATHOLIEKE UNIVERSITEIT LEUVEN1
LA SANTE EPIDEMIOLOGIE EVALUATION ET RECHERCHE LASER1
MCROBERTS BV1
MERCK SHARP & DOHME CORP1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU1
NOVO NORDISK1
PENUMOLOGISCHES FORSCHUNGSINSTITUTAN DER LUNGENCLINIC GROSSHANSDORF1
ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TEAM IT RESEARCH SL1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED1
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE FOUNDATION FOR MEDICAL RESEARCH INFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV1
THE SYNERGIST1
THE UNIVERSITY OF SHEFFIELD1
UNIVERSITA DEGLI STUDI DI SASSARI1
UNIVERSITA VITASALUTE SAN RAFFAELE1
UNIVERSITAET ZUERICH1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITATSKLINIKUM ERLANGEN1
UNIVERSITY COLLEGE DUBLIN1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UNIVERSITY OF NORTHUMBRIA AT NEWCASTLE1
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV1
VITAL TRANSFORMATION1
VRIJE UNIVERSITEIT AMSTERDAM VERENIGING VOOR CHRISTELIJK WETENSCHAPPELIJK ONDERWIJS1
ZORGINSTITUUT NEDERLAND1

Constancy:

Total number of partners: 84
Partner loyalty:
Frequent Partner: (> 2 projects): 6
Rare Partner: 78
Frequent / Rare Partner Ratio: 0.08

Project overview:

Start dateProjectacronymrolefundingpartners
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93135